Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1980 1
2004 1
2007 1
2016 1
2017 4
2018 3
2019 4
2020 5
2021 4
2022 3
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Results of the observational prospective RealFLOT study.
Giommoni E, Lavacchi D, Tirino G, Fornaro L, Iachetta F, Pozzo C, Satolli MA, Spallanzani A, Puzzoni M, Stragliotto S, Sisani M, Formica V, Giovanardi F, Strippoli A, Prisciandaro M, Di Donato S, Pompella L, Pecora I, Romagnani A, Fancelli S, Brugia M, Pillozzi S, De Vita F, Antonuzzo L. Giommoni E, et al. Among authors: pecora i. BMC Cancer. 2021 Oct 8;21(1):1086. doi: 10.1186/s12885-021-08768-7. BMC Cancer. 2021. PMID: 34625033 Free PMC article.
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes.
Tibaldi C, Mazzoni F, Scotti V, Vasile E, Pozzessere D, Stasi I, Camerini A, Federici F, Meoni G, Caparello C, Turrini M, Rossi V, Ciccone LP, Pecora I, Fantechi B, Antonuzzo L, Giannarelli D, Baldini E. Tibaldi C, et al. Among authors: pecora i. Anticancer Agents Med Chem. 2022;22(7):1278-1285. doi: 10.2174/1871520621666210727112212. Anticancer Agents Med Chem. 2022. PMID: 34315390
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Vivaldi C, Fornaro L, Ugolini C, Niccoli C, Musettini G, Pecora I, Cacciato Insilla A, Salani F, Pasquini G, Catanese S, Lencioni M, Masi G, Campani D, Fontantini G, Falcone A, Vasile E. Vivaldi C, et al. Among authors: pecora i. Oncologist. 2020 Oct;25(10):886-893. doi: 10.1634/theoncologist.2019-0922. Epub 2020 May 11. Oncologist. 2020. PMID: 32353192 Free PMC article.
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
Orsi G, Tovoli F, Dadduzio V, Vivaldi C, Brunetti O, Ielasi L, Conti F, Rovesti G, Gramantieri L, Rizzato MD, Pecora I, Argentiero A, Teglia F, Lonardi S, Salani F, Granito A, Zagonel V, Marisi G, Cabibbo G, Foschi FG, Benevento F, Cucchetti A, Piscaglia F, Cascinu S, Scartozzi M, Casadei-Gardini A. Orsi G, et al. Among authors: pecora i. Target Oncol. 2020 Dec;15(6):773-785. doi: 10.1007/s11523-020-00757-3. Target Oncol. 2020. PMID: 33044683
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
Vivaldi C, Salani F, Rovesti G, Pecora I, Catanese S, Casadei-Gardini A, Massa V, Bernardini L, Riggi L, Andrikou K, Rapposelli GI, Formica V, Lencioni M, Falcone A, Vasile E, Fornaro L. Vivaldi C, et al. Among authors: pecora i. Eur J Cancer. 2020 Sep;137:108-116. doi: 10.1016/j.ejca.2020.06.031. Epub 2020 Aug 1. Eur J Cancer. 2020. PMID: 32750500
31 results